PPARA and carcinoma: PPAR-α null mice are resistant to theeffects of peroxisome proliferators (e.g., clofibrate) and PPAR-α ligands (e.g., Wy-14,643) as well as to the development ofhepatocellular carcinoma in response to peroxisome proliferators [24].